Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

15.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Natural Pueraria─Based Conductive Cardiac Patch with Tree Frog Foot─Inspired Morphology for Myocardial Infarction Treatment.

ACS nano·2026
Same author

Radical-Mediated, Substrate-Independent Fabrication of Hybrid Solid-Hydrogel Materials With Tunable Crosslinking: An Initiator- and Crosslinker-Free Approach.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Sulfide-based, pro-regenerative, anti-inflammatory vascular grafts: Impregnation of slow-released sulfide signals into graft implants.

Acta biomaterialia·2025
Same author

Programmed modulation of inflammation in diabetic wounds via a dual-stage CuTA/RvD1 microneedle system.

Biomaterials advances·2025
Same author

Plasma-reinforced dual-crosslinked Pueraria hydrogel coating for synergistic atherosclerosis intervention.

Materials today. Bio·2025
Same author

Universal Method for Covalent Attachment of Hydrogels to Diverse Polymeric Surfaces for Biomedical Applications.

Advanced materials (Deerfield Beach, Fla.)·2025

Related Experiment Video

Updated: Jan 7, 2026

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
09:36

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

9.3K

Intelligent Responsive PLGA-ES100 Composite Nanoparticles Loaded with Resolvin E1 for Inflammation Regulation

Maolin Sun1,2, Yi Han1,2, Leila Mamizadehjanghour3

  • 1Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.

ACS Applied Bio Materials
|December 25, 2025
PubMed
Summary
This summary is machine-generated.

This study developed pH-responsive nanoparticles that release anti-inflammatory Resolvin E1 (RvE1) in alkaline conditions, improving immune response control around biodegradable implants and reducing fibrosis.

Keywords:
PLGA-Eudragit S100 nanoparticlesRvE1inflammation regulationmacrophage behaviorpH-sensitive

More Related Videos

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

66.4K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.7K

Related Experiment Videos

Last Updated: Jan 7, 2026

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
09:36

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

9.3K
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

66.4K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.7K

Area of Science:

  • Biomaterials Science
  • Immunomodulation
  • Drug Delivery Systems

Background:

  • Biodegradable implants require precise immune modulation control at the implant site.
  • Magnesium alloys create an alkaline environment during degradation, posing challenges for immune response.
  • Current strategies lack spatiotemporal control over immune responses.

Purpose of the Study:

  • To engineer pH-responsive nanoparticles for controlled drug release in alkaline environments.
  • To investigate the immunomodulatory effects of Resolvin E1 (RvE1) released from nanoparticles.
  • To assess the efficacy of the system in reducing fibrosis around magnesium alloy implants.

Main Methods:

  • Developed poly(lactide-co-glycolide) and Eudragit S100 (PLGA-ES100) nanoparticles.
  • Engineered nanoparticles to degrade under alkaline conditions for on-demand RvE1 release.
  • Implanted nanoparticles with AZ31 magnesium alloys in a rat subcutaneous model.

Main Results:

  • PLGA-ES100 nanoparticles released RvE1 specifically under alkaline conditions.
  • Nanoparticles promoted M2 macrophage polarization and suppressed pro-inflammatory cytokines (TNF-α, IL-1β).
  • In vivo implantation showed significantly reduced fibrotic capsule thickness and increased CD163 expression.

Conclusions:

  • pH-responsive nanoparticles offer a strategy for localized, inflammation-resolving drug release triggered by implant degradation.
  • The PLGA-ES100-RvE1 system provides a modular platform for controlling immune responses at bioresorbable implant interfaces.
  • This approach enhances the biocompatibility of biodegradable implants by modulating the local immune environment.